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Iron supplements are widely consumed; however most of the iron is not absorbed and enters the colon where potentially pathogenic bacteria can utilise it for
growth. This study investigated the effect of iron availability on human gut microbial composition and function using an in vitro colonic fermentation model
inoculated with faecal microbiota from healthy adult donors, as well as examining the effect of iron on the growth of individual gut bacteria. Batch fermenters
were seeded with fresh faecal material and supplemented with the iron chelator, bathophenanthroline disulphonic acid (BPDS). Samples were analysed at
regular intervals to assess impact on the gut bacterial communities. The growth of Escherichia coli and Salmonella typhimurium was significantly impaired when
cultured independently in iron-deficient media. In contrast, depletion of iron did not affect the growth of the beneficial species, Lactobacillus rhamnosus, when
cultured independently. Analysis of the microbiome composition via 16S-based metataxonomics indicated that under conditions of iron chelation, the relative
abundance decreased for several taxa, including a 10% decrease in Escherichia and a 15% decrease in Bifidobacterium. Metabolomics analysis using 1 H-NMR
indicated that the production of SCFAs was reduced under iron-limited conditions. These results support previous studies demonstrating the essentiality of iron
for microbial growth and metabolism, but, in addition, they indicate that iron chelation changes the gut microbiota profile and influences human gut microbial
homeostasis through both compositional and functional changes.
© 2019 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Humans are host to a wide variety of microbes which develop
ecosystems that are speciﬁc to any one individual but which are
subjected to a life-long process of colonisation by foreignmicrobes [1].
Through evolution, an environment of mutualism has been created
whereby many host-bacterial associations have become beneﬁcial
relationships; such as is found in the large intestine (colon), which is
home to the highest number ofmicrobes (N100 trillion bacteria) in our
body. Commensal bacteria of the mammalian gut have long been
recognised for the advantages they confer to the host. The beneﬁts
include defence against opportunistic pathogens, metabolism of☆ Declaration of interest: None.
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involvement in the development of the intestinal structure [2,3],
whilst also producing metabolites, such as SCFAs that contribute
towards providing energy to host cells [4–6]. The human gut
microbiome also contributes towards the basic developmental
features and functions of the immune system [7]. Conversely,
perturbations (e.g. antibiotic treatment and/or overgrowth of patho-
genic bacteria) in these symbiotic relationships, termed dysbiosis, can
lead to a negative impact on the host's health [8]. Dysbiosis has been
associated with a range of human disease states, such as autoimmune
disorders [9,10] increased vulnerability to cancers [11], irritable bowel
syndrome [12–15], and obesity [16], and research on these associa-
tions, including an understanding of the mechanisms involved, is a
high priority. The number of studies examining the relationship
between diet and the gut microbiome has increased over the past
years and has shown that the gut microbiome composition and
metabolism are signiﬁcantly affected by diet [17].
Iron, an essential nutrient for humans, is highly abundant in the
environment and involved in numerous biological processes such as
hydrogen production, respiration, and DNA biosynthesis. It also
functions as a co-factor in numerous metabolic pathways within aCC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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In humans, the absorption of iron by the epithelial cells of the small
intestine is a very tightly regulated process due to the absence of
excretory pathways [18]. The efﬁciency of absorption depends on the
potential availability of iron in the diet, and is regulated by
physiological iron requirements, including body iron stores, with
hepcidin having a central role in the control of absorption [19].
Dietary iron has been broadly classiﬁed into two types, non-haem
and haem iron. Both forms of dietary iron have a separate pathway of
uptake by enterocytes, where haem iron is better absorbed (25–30%)
compared to the poorly absorbed non-haem iron, (0–15% absorbed)
despite being the most common form of iron present in the diet [20].
The unabsorbed iron travels to the large intestine, and there is
accumulating evidence to suggest that this unabsorbed colonic iron
can facilitate the growth of intestinal pathogens [21].
The vast majority of bacteria in the gut require iron for growth and
development, and they have formulated many strategies to acquire
this nutrient, which in its more common state (Fe3+) has low or zero
solubility. Potentially pathogenic bacteria make use of a continuous
supply of micronutrients, such as iron, formetabolism and replication.
Thus, there is constant competition for iron between various bacteria,
many of which have developed mechanisms, such as siderophore
production, to acquire iron, particularly when availability is limited.
Unlike most bacteria, members of the Biﬁdobacteriaceae and
Lactobacilliaceae families (two families that are believed to be
beneﬁcial to the host [22–25]) have a very limited need for iron [26].
Lactobacilli do not produce siderophores to sequester iron, and their
growth is similar in media with andwithout iron [27]. Biﬁdobacterium
breve, an important member of the Biﬁdobacterial species in breast-
fed infants, can acquire luminal iron with the help of a divalent metal
permease, however, many of the Biﬁdobacterium species do not
synthesise siderophores or other forms of iron-carriers. The human
bodyhas createdmanyways to promote the growthof these beneﬁcial
bacteria, such as the presence of lactoferrin in breast milk, which
travels intact to the large intestine [28–30],whichwith its high afﬁnity
for iron, renders the iron unavailable to potentially pathogenic
bacteria [31]. Along with high amounts of dietary iron in the gut
lumen, the oral administration of iron supplements also results in
freely available “unbound” iron in the colon [32–34]. This disturbs iron
homeostasis consequently modifying the gut microbial composition
[35–37].
An emerging link between the gutmicrobiome and iron availability
has been observed, however several studies that have investigated the
effects of iron on the human gutmicrobiota aremainly focussed on the
infant microbiome [6,33–35,38–40]. Other studies have looked at the
role of iron in the gut microbiota in individuals with either metabolic
[41] or iron disorders and therefore, this study was designed to use in
vitro colon models that mimic the microbiological conditions of the
human large intestine to assess the impact of iron limitation on
structure and function of the complex gut bacterial communities of
healthy adults.
2. Materials and methods
2.1. Bacterial strains and growth conditions
To evaluate the role of iron on bacterial growth, the following bacterial strains were
chosen: Escherichia coli 1BO4 (isolated from human faeces), Biﬁdobacterium longum
B78 F110564 (isolated from human faeces), Lactobacillus rhamnosus GG F111027,
Salmonella Typhimurium (ATCC SL1344), Clostridium perfringens (NCTC 3110) and
Bacteroides thetaiotaomicron VP1–5482 (ATCC 29148). Bacteria were cultured in the
following media: Luria (L) Broth (E. coli and S. Typhimurium); Brain Heart Infusion
(BHI; B. longum); BHI supplemented with vitamin K (0.5% v/v), hemin (0.5 mg/mL),
resazurin (0.02% w/v) and L-cysteine (0.5 g/L) (C. perfringens) and BHI with hemin
(B. thetaiotaomicron); De Man, Rogosa and Sharpe (MRS) supplemented with glucose
(L. rhamnosus). All bacteria were grown under anaerobic conditions at 37 °C. E. coli and
S. Typhimurium were agitated at medium speed throughout the growth period, whilst
the remaining bacteria were grown under static conditions.2.2. The effect of iron chelation on bacterial pure cultures
Bacterial cultures were grown overnight in rich media speciﬁed above. Cultures
were seeded in 100-well honeycomb plates and cells were then provided with
bathophenanthrolinedisulfonic acid disodium salt hydrate (BPDS; B1375, Sigma, United
Kingdom) atﬁnal concentrations ranging from 0–50 μM. Sampleswere analysed using a
Magellan Microplate Reader (Tecan Life Sciences, Switzerland), which monitors the
growth of microorganisms by measuring the turbidity of the culture (optical density,
OD600) of the liquid growth medium. The experiments were run for 24 h, with OD600,
taken every 10 min. The experiments were performed at 37 °C under anaerobic
conditions.
2.3. In vitro colonic fermentations
Ten grams of fresh faecal samples obtained from healthy volunteers were diluted
1:10 in deoxygenated phosphate buffered saline (pH 7.7), and homogenised using a
Stomacher 400 (Seward, United Kingdom) at 230 rpm for 45 s. All samples were
processed within 4 h of stool collection.
Theworking volume of each vesselwas set at 150mL, ofwhich 15mLwas processed
faecal inocula and 135 mL was nutritive media (peptone water 2 g/l, yeast extract 2 g/l,
NaCl 0.1 g/l, K2HPO4 0.04 g/l, KH2PO4 0.04 g/l, MgSO4.7H2O 0.01 g/l, CaCl2.6H2O 0.01 g/l,
NaHCO3 2 g/l, Tween 80 2 ml, glucose 10 g/l, vitamin K1 10 μl, cysteine HCl 0.5 g/l, bile
salts 0.5 g/l, pH 7.0). The pH was controlled and maintained between 6.6–7.0 using pH
control units Fermac 260 (Electrolab, United Kingdom), connected to 1MNaOH and 1M
HCL solutions. Vessels were kept at 37 °C by a circulating water jacket and anaerobiosis
was maintained by continuous bubbling of the system with oxygen-free nitrogen gas.
Conditions testedwere either nutritivemediawith faecal inocula only (Control), orwith
faecal inocula and BPDS (70 μM). The concentration of BPDS was chosen as a result of
preliminary experiments investigating the baseline faecal iron concentrations in
multiple healthy donors (data not shown). We used 70 μM BPDS as we calculated that
this concentrationwould be sufﬁcient to chelatemost of the iron in the colon. Per donor,
1 vessel was used for each condition. Samples were taken at 0, 4, 8, and 24 h from each
vessel, serially diluted in PBS and enumerated on selective agar plates [42]. Faecal
samples used in the colon model experiments were obtained from participants
recruited onto the QIB ColonModel study. Men and women aged 18 years or older who
live or work within 10 miles of the Norwich Research Park were recruited onto the QIB
Colon Model study if they satisﬁed the following criteria. Participants who were
assessed to have a normal bowel habit, regular defecation between three times a day
and three times a week, with an average stool type of 3–5 on the Bristol Stool Chart, and
no diagnosed chronic gastrointestinal health problems, such as irritable bowel
syndrome, inﬂammatory bowel disease, or coeliac disease were eligible to enrol onto
the study. Demographic informationwas collected, and a brief health questionnairewas
completed during the eligibility screening. Participantswere asked additional questions
immediately prior to donating a stool sample to conﬁrm that they had not taken
antibiotics or probiotics within the last four weeks, had not experienced a
gastrointestinal complaint, such as vomiting or diarrhoea, within the last 72 h, were
not currently pregnant or breast-feeding, had not recently had an operation requiring
general anaesthetic, and were not taking iron or multivitamin supplements. The study
was approved by theQuadram Institute Bioscience (formally Institute of FoodResearch)
Human Research Governance committee (IFR01/2015), and London - Westminster
Research Ethics Committee (15/LO/2169). The informed consent of all participating
subjects was obtained, and the trial is registered at http://www.clinicaltrials.gov
(NCT02653001).
2.4. DNA extraction for 16S rDNA based metagenomics
DNA was extracted from all samples collected from in vitro colonic fermentations
using a commercially available kit (FastDNA spin kit for soil; MP Biomedicals, USA, Cat
No. 6560200). Samples were thawed on ice, homogenised, and approximately 200 mg
of each were used to extract DNA following manufacturer's instruction, with an
additional bead beating step using FastPrep (MP Biomedicals, USA), as previously
described by Kellingray et al. [43].
2.5. 16S rRNA gene amplification and sequencing
The impact of iron on the composition of the human gut microbiome was
investigated using high throughput 16S rRNA gene (V4 region) sequencing using the
Illumina Miseq platform, followed by data analysis using the Quantitative Insights into
Microbial Ecology (QIIME, V1.9) pipeline. Each sample sequence was ﬁltered to read
lengths between minimum 200 and maximum 1000 bp. ChimeraSlayer was used to
ﬁlter trimmed reads for chimeric sequences after which Shannon index were used to
create alpha diversity plots. Weighted UniFrac data were used to produce beta diversity
PCoA plots, using the XLSTAT add-on package on Microsoft Excel.
2.6. Short chain fatty acid quantification in cultured microbiomes
Faecal water was prepared to quantify short chain fatty acids in stool. Brieﬂy,
samples (13 mL) taken from colonic batch fermentations were centrifuged at 3220×g
for 15 min at 4 °C. 100 μl NMR buffer (0.26 g NaH2PO4 and 1.41 g K2HPO4 made up in
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propionate-d4, (TSP) (17 mg) as a chemical shift reference) was added to 900 μl
supernatant and analysed using 1H NMR spectroscopy (this mixture is deﬁned as ‘faecal
water’). The 1H NMR spectra were recorded at 600 MHz on a Bruker Advance
spectrometer (Bruker BioSpin GmbH, Germany) running Topspin 2.0 software and
ﬁttedwith a cryoprobe and a 60-slot autosampler. Each1HNMR spectrumwas acquired
with 256 scans, a spectral width of 12,300 Hz, and an acquisition time of 2.67 s. The
“noesypr1d” pre-saturation sequence was used to suppress the residual water signal
with a low-power selective irradiation at the water frequency during the recycle delay
and a mixing time of 10 ms. Spectra were transformed with a 0.3 Hz line broadening,
and were manually phased, baseline corrected, and referenced by setting the TSP
methyl signal to 0 ppm. Themetabolites were quantiﬁed using the software Chenomx®
NMR Suite 7.0™.
2.7. Quantification of iron levels in fermentation samples
A 20 μl aliquot of the faecal water prepared in Section 2.6 was used to quantify iron
concentrations of the fermentation samples at 0, 8 and 24 h using the ferrozine assay as
permanual instructions (Iron Assay Kit ab83366, Abcam, UK). Brieﬂy, iron in the sample
is reduced using an Fe reducer, provided by the kit, afterwhich iron reacts with Ferene S
(an iron chromogen) to produce a stable coloured complex. Absorbancemeasurements
were taken at 593 nm.
2.8. Statistical analysis
Data from pure culture experiments and in vitro colonic fermentations were
expressed as means±S.E.M. Pure cultures were analysed using one-way ANOVA
followed by Bonferroni post-tests with GraphPad Prism software (Version 5.04), whilst
in vitro colonic batch fermentations were analysed using unpaired t tests assuming
unequal variances on Microsoft Excel. Pb.05 was considered statistically signiﬁcant.
3. Results
3.1. Iron chelation significantly reduced the growth of selected bacterial
species grown in pure cultures
For pure culture experiments, we wanted to test a range of gut
bacteria that are known to be affected or unaffected by iron, but the
selection, to some extent, depended on what was available in the
laboratory. Therefore, various bacterial species were treated with
different concentrations (0, 10, 20, and 50 μM) of BPDS in triplicate for
24 h to determine the effect of iron chelation on their growth. A dose-
dependent reduction in the growth of E. coli, S. Typhimurium and B.
thetaiotaomicron (Pb.0001), were observed in the presence of BPDS, at
24 h (Fig. 1A-C). As expected, L. rhamnosus, a bacterial species known
to be able to grow in the absence of iron, exhibited comparable growth
to the BPDS-free (0 μM)culture, conﬁrmingprevious observations that
iron is not an essential nutrient for the survival of this bacterial species
(Fig. 1E). A decrease was also observed in the growth of B. longum
(Pb.01) upon iron chelation (Fig. 1D). These results support the idea
that iron is an essential nutrient for bacteria, and in its absence the
growth of many bacteria is restricted.
3.2. Reduced iron availability decreased the growth of potentially
pathogenic bacteria under in vitro colonic fermentation conditions
Batch fermentations were performed for 24 h to elucidate the
effects of iron depletion on the human gut microbiome by enumer-
ating speciﬁc bacterial groups using selective agar plates. Counts from
the control vessel of the three individual experiments were ﬁrst
normalised to 100% and thereafter, viable counts from the iron-
chelated vessels were shown as percentages in relation to the Control.
Finally, the data from the three individual experiments were
combined and average percentages (±SEM) presented (Table 1).
Results showed a decrease in the viable counts of a number of bacterial
groups, including Enterobacteriaceae (Pb.05 at 8 and 24 h), Biﬁdo-
bacteria (Pb.001 at 8 h) and Lactobacilli (Pb.01 at 8 and 24 h), upon
iron chelation at 8 h and 24 h (Table 1). It should be noted that the high
viable counts of Biﬁdobacteria at 24 h is attributed to a single donor.The remaining two donors displayed a substantial reduction in the
viable counts of Biﬁdobacteria under iron-chelated conditions.
3.3. 16S rRNA gene sequencing revealed a decrease in the relative
abundance of potentially pathogenic bacterial genera in response to
iron limitation
High-throughput paired-end sequencing of the 16S rRNA gene (V4
region) was performed on fermentation samples using the Illumina
Miseq platform, and microbial communities present in relative
abundances≥0.5% are illustrated in Fig. 2. After combining and
averaging the abundance values from the three individual experi-
ments, the data revealed that the most abundant genera at 0 h were
Escherichia (16.1%), followed by Bacteroides (8.7%), (Fig. 2, SEM values
can be found in Table 2). It is worth noting that the relative abundance
of Escherichia is entirely attributed to one donor only, as the remaining
two donors had no more than 0.1% Escherichia present at T0.
Brieﬂy, the relative abundance of Escherichia was reduced substan-
tially in the iron chelated fermentation vessel in comparison to the
control vessel at 8 h (0.8% vs. 10.7%) and24h (2.3%vs. 5.3%) (Fig. 2). This
correlates well with the reduction in the viable counts for Enterobac-
teriaceae (Table 1). Again, it is worth noting that the high relative
abundance of Enterobacteriaceae at T8 and T24 for both control and
chelator conditions, is entirely attributed to the levels observed in one
donor only, since in the other two donors, the levels were below the
detectable limit. A similar trend was observed for Biﬁdobacterium,
where the relative abundance was much lower at T8 and T24 under
iron-chelated conditions (4.1% vs. 15% and 14% vs. 29%, respectively),
which is also reﬂected in the viable counts results for Biﬁdobacteria at
8 h. Interestingly, 16S rDNA analysis indicated that at 24 h, the relative
abundance of Streptococcus increased to 36% in the iron chelated
condition compared to the starting proportion of 4.7%. Iron-depleted
conditions have been shown to proportionally decrease many bacterial
groups, and this may provide other bacteria, such as Streptococcus, with
a competitive advantage resulting in their increased growth. This could
also be true for Bacteroides, as the relative abundances of this genus
increased at both8 h (10.6% to 18.1%) and 24h (2.7% to 4.4%) under iron
chelated conditions. Finally, 16S rDNA analysis indicated that Clostri-
dium abundance was largely unaffected by iron removal (Fig. 2), and
this was reﬂected in the viable counts for Clostridia (Table 1).
3.4. Iron chelation resulted in a shift in bacterial diversity profiles
Alpha (α) – and beta (β) – diversity was measured for all in vitro
colonic fermentation samples tested. The Shannon index, which is a
measure of α- diversity, showed a minimal difference in diversity
within the population in the absence of the chelator (Fig. 3a).
However, an increase in population diversity was observed at 8 h in
the presence of BPDS. The principal coordinates analysis (PCoA) plot
(Fig. 3b), using the weighted UniFrac metric, which depicts β-
diversity, indicates that the microbiotas of the subjects before and
after iron chelation did not have a large range of taxa in common.
Interestingly, at both 8 h and 24 h, a shift in β-diversity was observed
upon iron chelation when compared to the control at the respective
time points, depicted by the dashed line.
3.5. Levels of short chain fatty acids decrease upon iron chelation during
in vitro colonic fermentation
1H-NMR spectroscopy was used to determine the levels of over 70
metabolites from samples taken from the fermenters at 0, 8, and 24 h.
The three metabolites which showed the most substantial changes
between treatments, were the short chain fatty acids (SCFAs), acetate,




Fig. 1. The effect of iron chelationwith BPDS on pure bacterial cultures. A strain of E. coli isolated fromhuman gut (1A), S. Typhimurium (1B), B. thetaiotaomicron (1C) B. longum (1D) and
L. rhamnosus (1E)were cultured anaerobically overnight in selective richmedia. Cultureswere supplementedwith BPDS, at 0 (control), 10, 20 and 50 μM.Optical densitymeasurements
were taken every 10 min for a period of 24 h and growth curves were plotted for each strain. Data shown = mean and are representative of 3 independent experiments. The data was
statistically analysed using, one-way ANOVA, comparing the different concentrations of BPDS to the control, over a period of 24 h; **Pb.01, ****Pb.0001 versus control (0 μM BPDS).
23B.A. Parmanand et al. / Journal of Nutritional Biochemistry 67 (2019) 20–27Acetateconcentrationswas~25.3mMundercontrol conditions(i.e.0μM
BPDS) at 8 hwith lower levels (~6.3mM) foundwhen ironwas chelated
(with 70 μM BPDS) at the same time-point. The same trend wasTable 1
The effect of iron chelation via BPDS on gut-derived bacterial communities
Bacterial Group
Viable Counts % (“Control” normalised to 100%, ±SEM)
T8 T24
Control (+)BPDS Control (+)BPDS
Total Anaerobes 100 27.83±9.47 * 100 29.30±7.46 *
Bacteroides 100 68.71±31.61 100 29.70±18.47
Biﬁdobacteria 100 5.38±1.05 *** 100 110±106.30
Clostridia 100 63.58±25.84 100 432.89±299.18
Lactobacilli 100 8.21±5.10 ** 100 35.47±5.92 **
Enterobacteriaceae 100 19.01±11.19 * 100 17.65±15.04 *
Two vessels were set up containing nutritive media and faecal inocula; one vessel was
supplemented with BPDS (70 μM BPDS) whilst the other was used as a control (0 μM
BPDS). Samples were taken from each vessel at 0, 8, and 24 h, and then enumerated
using selective agar plates. Data shown = mean of 3 individual experiments±S.E.M.
The data was statistically analysed using unpaired t-test, assuming unequal variance;
*Pb.05, **Pb.01, ***Pb.001 and ****Pb.0001 for Control versus viable counts at the
relevant time-point.observed at 24 h where acetate concentrations were~33.3 mM in the
control vessel whereas under iron-limitation, its levels were reduced
to~25.6 mM. Levels of propionate and butyrate exhibited the same
patternundercontroland iron-chelatedconditions. In thecontrol condition,
~1.1 mM (8 h) and~6.8 mM (24 h) of butyrate was measured whereas
under iron-chelation, butyrate levelswere reduced(~0.4mMat8hand~3.6
mM 24 h) representing 47% reduction at 24 h. This is reﬂected in the
reduction observed for the relative abundances of the members of the Ru-
minococcus (3.9% to 1.5%) genera, which are common butyrate producers.
Although similar propionate levels were observed between the
different conditions at 8 h, propionate concentrations were lower in
the iron-chelated vessel compared to the control at 24 h (~10.5mMvs.
~3.5 mM). This represents a 67% decrease in production at 24 h under
iron-limiting conditions. This is in linewith the 70% decrease observed
in the viable counts of Bacteroides (a genus containing propionate
producers) under low iron conditions (Table 1).4. Discussion
Iron supplements are consumed widely, but the majority of the
iron passes through to the colon where it can be utilised by iron-
Fig. 2.Microbial community proﬁles assessed by 16S rRNA gene analysis. Microbial composition of both vessels (Control and BPDS). Proportions shown are of themost abundant genera
(≥0.5%, identiﬁcation to genus level where possible) identiﬁed by sequencing of the V4 hypervariable regions of the 16S rRNA gene. Data shown is the average relative abundance from
the 3 individual experiments from 3 different donors and analysed using the QIIME pipeline. SEM values can be found in Table 2.
Table 2
Proportions of different bacterial taxa (SEM) illustrated in 16S rRNA gene analysis
Taxa SEM
T0 T8 Control T8 BPDS T24 Control T24 BPDS
g__Biﬁdobacterium 3.54 6.91 2.09 13.43 6.47
g__Collinsella 0.66 3.55 1.32 3.49 0.71
g__Bacteroides 3.17 3.33 10.06 0.80 2.90
g__Prevotella 5.45 3.07 2.33 0.13 0.30
f__Rikenellaceae 0.41 0.06 0.32 0.19 0.12
g__Enterococcus 0.03 0.03 0.03 0.02 1.25
f__Leuconostocaceae 0.60 0.03 1.97 0.03 3.92
g__Streptococcus 4.45 0.35 0.19 0.30 15.70
g__Turicibacter 0.32 0.19 0.15 0.00 0.03
o__Clostridiales 0.52 0.15 1.83 0.12 0.06
g__Clostridium 1.38 0.06 0.22 0.06 0.09
f__Clostridiaceae;g__SMB53 1.56 0.10 0.47 0.17 0.07
f__Lachnospiraceae 0.30 0.04 0.18 0.29 0.08
f__Lachnospiraceae 0.54 0.44 1.96 0.55 0.17
g__Blautia 1.25 2.10 4.19 2.77 0.55
g__Coprococcus 1.39 2.78 2.17 3.42 0.17
g__Dorea 0.15 0.64 0.55 0.42 0.28
g__Lachnospira 0.20 0.00 0.45 0.00 0.00
g__Roseburia 0.82 0.17 0.85 0.13 0.00
g__[Ruminococcus] 1.10 1.84 2.66 1.91 1.39
f__Ruminococcaceae 0.78 0.00 0.70 0.03 0.00
g__Faecalibacterium 1.66 1.37 5.58 0.35 0.12
g__Oscillospira 1.69 0.19 0.67 0.44 0.22
g__Ruminococcus 2.32 0.25 1.75 0.15 0.45
g__Phascolarctobacterium 0.88 1.15 1.31 0.44 0.21
g__Veillonella 0.12 0.00 0.03 0.55 0.10
f__Erysipelotrichaceae 0.34 1.30 0.29 1.23 0.07
g__Sutterella 0.47 0.93 1.14 0.40 0.73
f__Enterobacteriaceae 0.37 28.13 25.50 25.70 23.90
g__Escherichia 16.08 5.86 0.23 2.61 1.72
g__Klebsiella 0.03 1.36 0.90 1.06 1.17
g__Akkermansia 7.95 0.22 0.39 0.15 0.21
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colonic iron chelation on the humangutmicrobiota.We found that the
addition of BPDS, a chemical iron chelator, signiﬁcantly reduced the
growth of E. coli, S. Typhimurium, B. thetaiotaomicron and B. longum
(Fig. 1). These results conﬁrm well-established knowledge that iron
promotes the growth of potentially pathogenic bacteria. However,
Cronin et al., [44] reported that the growth of two B. longum strains
were largely unaffected in the presence of an iron chelator, even at the
highest chelator concentration (5 μM), suggesting that the effect of
iron chelation on Biﬁdobacteria could be largely strain-dependent. In
the same study [44], no effect on the growth of L. rhamnosus was
observed and it is known that Lactobacillus does not require iron for
growth due to an absence of haem-containing enzymes. However,
they can substitute other metals for iron, such as cobalt and
manganese [45], which may give these bacteria a competitive
advantage in low-iron conditions.
The net effects of iron on the gut microbial composition are still
inconclusive and need further research as the results reported are
inconsistent [6,39,44,45]. Our study showed a marked effect on the
global microbiome composition when iron was chelated in the
fermentation media with BPDS (Fig. 2). BPDS acts as a chelator of
various metals and, in particular, it has been shown to bind iron with
very high afﬁnity and has therefore been used as an iron chelator in
many studies [46,47]. Comparison of the relative abundance of
bacterial taxa between the two conditions (control and BPDS)
illustrated that the most apparent differences were the decreased
relative abundance of the potentially pathogenic Escherichia. The
observed decrease of Biﬁdobacterium is interesting as other studies
have reported different outcomes, which could be due to strain
speciﬁcity, inter-individual variability of the host, aswell as the effects
Fig. 3. Bacterial diversity proﬁles of colonic fermentation samples. (a) α- diversity analysis of batch fermentation samples with (BPDS) and without iron chelator (No BPDS) using the
Shannon index and (b) β- diversity analysis of batch fermentation samples portraying weighted analysis of samples with (BPDS) and without (control) iron chelator using the UniFrac
metric and presented as a PCoAplot. Data shown is the average Eigenvalues from the 3 individual experiments from3different donors. Each colour represents a different donor. Analysis
was performed using QIIME (V1.9) and visualised using the XLSTAT add-on package in Microsoft Excel.
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dance of Clostridium remained relatively stable, which has been
observed in other studies. Notably, Streptococcus, a member of the
lactic acid bacteria group towhich Lactobacillus also belongs, was seen
to increase upon iron removal, and this could potentially lead to
restricted growth of other bacteria in the gut environment.
Studies investigating the effects of iron supplementation report
comparable results to those found in this study in relation to the
relative abundance of various bacterial taxa, including Escherichia.
One study examined the effects of low and high doses of in-home iron
supplementation on the gut microbiome of Kenyan children [39]. In
this setting, provision of iron-fortiﬁed porridge led to an increase in
pathogen abundance, with proportions of Enterobacteria, Clostridiumand E. coli increasing, whilst Biﬁdobacteria decreased. In addition,
children given iron-fortiﬁed porridge had elevated levels of faecal
calprotectin, amarker of gut inﬂammation, which is likely to reﬂect an
increased pathogenic proﬁle.
Much of the published literature focuses on the effects of iron on
the infant microbiome which may not be the same as adults. In
addition, geographical location is probably important, as studies have
shown that individuals from developing countries tend to have a
greater pathogenic microbial proﬁle due to the lack of clean food and
water, and, in turn, a compromised gut function. This is reﬂected in
two studies, where one investigated the effects of iron addition on the
gut microbiota of children from Cote d'Ivoire [48], the second study
focused on children from South Africa [6]. No detrimental effects of
Fig. 4. Metabolite concentrations of batch fermentation samples. Short chain fatty acid
concentrations in both vessels were measured using 1H-NMR spectroscopy, with
samples being screened for multiple metabolites against a spiked standard (TSP) and a
validated reference library. Data shown is the average±S.E.M. metabolite concentra-
tions from the 3 individual experiments from 3 different donors.
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water and food, yet the children that did not have access to clean
water, had adverse side effects.
We also performed bacterial diversity analysis. α- diversity
analysis using the Shannon index, which accounts for the distribution
and richness of OTUs within a population, showed an increase in
populationdiversity at 8 h in the presence of the iron chelator (Fig. 3a).
We speculate that the chelation of iron may lead to certain taxa
exploiting other metals as a means of replacing iron, and therefore
temporarily facilitating growth in a micronutrient-restricted environ-
ment. However, by 24 h, a visible decrease in diversity was observed
under iron-chelated conditions, suggesting an exhaustion of these
metals and nutrients. β-diversity analysis demonstrated that there
was not a large range of taxa in commonwhen comparing the control
samples to those that were cultured in iron-limiting conditions
(Fig. 3b). Interestingly, at both 8 h and 24 h, there was a shift in β-
diversity between the two groups. This is in line with a study
performedbyDostal et al., [49],which investigated the effect of iron on
butyrate production in the child gut microbiota, where altering the
iron concentration in the medium affected microbial community
structure as well as causing a shift in β-diversity.
Microbial metabolic activity contributes to human health. When
iron was chelated, we observed a decrease in the three main short
chain fatty acids (SCFAs) that are produced in the gut (Fig. 4), which
presumably reﬂects poor growth of fermentative microbes. Based on
the 16S rRNA gene sequencing data from this study and those
published elsewhere, we can infer the potential mechanisms behind
certain metabolic changes. Firstly, iron-dependent enzymes are
critical operators of many metabolic pathways, and therefore these
processes can be affected by differing iron concentrations. Moreover,
anymicrobial fermentation that takes place requires the redox balance
to be sustained. Due to the dual role of iron as an electron donor and
acceptor, we speculate that changes in iron levels could have a large
effect on redox balance. During the batch fermentation, the most
prominent effect observed on metabolite production was that of
acetate levels. Many gut bacteria produce acetate by either the
reductive acetyl-CoA pathway, which uses H2 and CO2 [50], or via the
regular glycolytic pathway through pyruvate metabolism [51]. The
former pathway consists of numerous iron-dependent enzymes and
can account forN25% of acetate produced in the gut [52]. It is therefore
plausible to speculate a lack of conversion of H2 and CO2 to acetate
under iron-limiting conditions, resulting in an overall decrease inacetate levels. This observation also correlated with the viable counts
and 16S rRNA gene analysis, where a decrease in the members of
Biﬁdobacterium, a prominent bacterial group which produces acetate,
was observed under iron-limiting conditions. Although correlations of
metabolite levels with the relative abundance of bacterial taxa do not
provide a causal relationship, it may still provide some indications as
to which taxa are responsible for any observed differences.
In conclusion, this in vitro study shows that the chelation of iron,
achievedwith BPDS, resulted in a decrease of themain intestinal SCFAs
and a lower relative abundance of potentially pathogenic bacteria
within the gut microbial community. This observation was also
conﬁrmed in pure culture studies with pathogenic bacteria. Taken
together, these data suggest that iron could provide an advantageous
niche for potentially pathogenic bacteria and highlights the impor-
tance of tight control of iron availability to avoid a pathogenic proﬁle
within the colon. The relationship between iron availability and the
human gut microbiome is yet to be fully elucidated, and more
extensive research on this topic will aid in expanding our knowledge
and understanding of this relationship, and in extension, help deﬁne
improved methods for maintaining gut microbial homeostasis.
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